EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Harnessing Polygenic Risk Scores to Refine Venous Thromboembolism Risk Stratification

Katlyn G McKay iD, Oliver S Zhao, Samaya S Badrieh, Lisa Bastarache, Xinnan Niu, Jing He, Prince J Kannankeril, Jamie R Robinson

European Journal of Haematology · 2026

DOI: 10.1111/ejh.70212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Katlyn G McKay und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Venous Thromboembolism, Genetic Predisposition to Disease, Multifactorial Inheritance. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agency of Healthcare Research and Quality, NCATS NIH HHS, CTSA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Venous thromboembolism (VTE) is a major cause of morbidity in patients of all ages. Despite growing interest in polygenic risk scores (PRS) for VTE, their utility remains understudied. Our objective was to evaluate the independent impact of a PRS on VTE susceptibility in adults and children.

Methods

We completed a retrospective, case–control study of two separate cohorts with evaluation of three VTE PRS models, with the primary analysis focused on a 293 single nucleotide polymorphism (SNP) PRS. The adult cohort included 597 VTE cases and 31 998 controls, and the pediatric cohort included 109 cases and 448 controls, both obtained from a de‐identified databank with linked genetic data. Separate adult and pediatric multivariable logistic regressions were performed to measure the association of risk factors with VTE.

Results

Higher PRS in adults was significantly associated with increased odds of VTE, with each 1‐standard deviation increase in PRS conferring an adjusted odds ratio of 1.25 (OR = 1.25, 95% CI 1.15–1.36, p < 0.001). Leading risk factors for adults were cancer (OR = 2.43, 95% CI: 2.04–2.89, p < 0.001) and recent surgery (OR = 2.16, 95% CI: 1.83–2.54, p < 0.001). The standardized PRS also exhibited increased risk for VTE in children (OR = 1.38, 95% CI 1.10–1.74, p = 0.003). Central venous catheterization (OR = 5.65, 95% CI 3.40–9.50, p < 0.001) was the foremost risk factor for pediatric VTE.

Conclusion

VTE in adults and children is multifactorial, with clinical and genome‐wide risk factors contributing. PRS may serve as a valuable adjunct to clinical risk factors for VTE risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismGenetic Predisposition to DiseaseMultifactorial InheritanceHumansGenetic Risk ScoreFemalePolymorphism, Single NucleotideAdultMiddle AgedRisk FactorsCase-Control StudiesChildMaleRisk AssessmentAgedAdolescentRetrospective StudiesChild, PreschoolOdds Ratio

Stichwörter der Autor:innen

genetic variantspolygenic risk scorevenous thromboembolism

Autor:innen und Institutionen

  • Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Information School, University of Washington, Seattle, Washington, USA.
  • Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Pediatrics, Center for Pediatric Precision Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Pediatric Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Katlyn G McKay

Förderung

  • Agency of Healthcare Research and Quality
  • NCATS NIH HHS
  • CTSA
  • AHRQ HHS
  • NCRR NIH HHS
  • NIH funded Shared Instrumentation
  • Georgia Clinical and Translational Science Alliance

Zitieren

APA

McKay, K. G., Zhao, O. S., Badrieh, S. S., Bastarache, L., Niu, X., He, J., Kannankeril, P. J., & Robinson, J. R. (2026). Harnessing Polygenic Risk Scores to Refine Venous Thromboembolism Risk Stratification. European Journal of Haematology. https://doi.org/10.1111/ejh.70212

Vancouver

McKay KG, Zhao OS, Badrieh SS, Bastarache L, Niu X, He J, et al. Harnessing Polygenic Risk Scores to Refine Venous Thromboembolism Risk Stratification. European Journal of Haematology. 2026. doi:10.1111/ejh.70212

BibTeX
@article{McKay2026,
  author = {McKay, Katlyn G and Zhao, Oliver S and Badrieh, Samaya S and Bastarache, Lisa and Niu, Xinnan and He, Jing and Kannankeril, Prince J and Robinson, Jamie R},
  title = {Harnessing Polygenic Risk Scores to Refine Venous Thromboembolism Risk Stratification},
  journal = {European Journal of Haematology},
  year = {2026},
  doi = {10.1111/ejh.70212}
}
Kostenlos starten →